Body Fluid Cell Counts and Cerebrospinal Fluid

Selecting and controlling a cell-count method

Manual hemacytometer counts remain useful for fluids with very low cell concentrations, analyzer flags, or specimen properties outside an automated method's validated limits. Automated body-fluid modes can improve speed and precision within their verified range. They may lose accuracy near the lower limit or misclassify atypical cells, microorganisms, debris, or crystals. The laboratory establishes which fluids can be analyzed, the reportable range, and the findings that trigger a manual count or morphologic review.^{1,21 Keohane EM, et al. Rodak's Hematology. 2025.2 Alcaide Martín MJ, et al. Automated cell count in body fluids. 2021.}

A clot can trap cells and make both the total count and differential unreliable. The usual response is to reject the specimen and request a new collection. When the specimen is irreplaceable, test it under the laboratory's policy and state the limitation clearly in the report.

Manual hemacytometer testing under the Clinical Laboratory Improvement Amendments (CLIA) includes duplicate patient and control counts. Two chamber measurements from one well-mixed dilution can satisfy the duplicate patient-count requirement. CLIA does not set one percentage agreement limit for all fluids. Each laboratory defines and verifies its own acceptance rule, repeat procedure, calculation, and reporting limits.^{3,43 Electronic Code of Federal Regulations. 42 CFR §493.1269.4 Centers for Medicare & Medicaid Services. State Operations Manual, Appendix C. 2024.}

Specimen-specific preparation

Appearance can guide the first dilution. Clear or slightly hazy fluid may be counted undiluted or at a low dilution. Densely cellular or bloody fluid usually needs a greater dilution. The method must place enough cells in a countable chamber area and remain within the laboratory's verified range. A red blood cell (RBC)-preserving aliquot and an RBC-lysing total nucleated cell (TNC) aliquot may therefore use different dilutions.

Viscosity can make mixing and air-displacement pipetting inaccurate. A positive-displacement pipette or another verified transfer method improves delivery of untreated viscous fluid. Validated hyaluronidase treatment can improve homogenization of synovial fluid. Keep an untreated aliquot when crystal analysis is requested, because pretreatment conditions can affect the examination. The later semen lesson covers semen fixatives and treatments for incomplete liquefaction.^{1,21 Keohane EM, et al. Rodak's Hematology. 2025.2 Alcaide Martín MJ, et al. Automated cell count in body fluids. 2021.}

Manual counting sequence

1. Inspect the specimen. Record its color, clarity, volume, and the presence of a clot or visible particles before mixing or centrifugation.
2. Mix the specimen by the validated method so cells are evenly suspended without unnecessary damage.
3. Choose the chamber, counted area, and dilution that place enough cells in a readable range. Use the specimen's appearance as a starting guide for the first dilution.
4. Prepare separate aliquots when red blood cells (RBCs) and total nucleated cells (TNCs) need different diluents. An isotonic, nonlysing diluent preserves RBCs. A validated lysing diluent can remove RBC interference from a TNC count. Acidic diluents can precipitate synovial-fluid hyaluronate, so follow the fluid-specific procedure.
5. Mix the dilution and load both chamber sides without bubbles, overfilling, or drying. Allow cells to settle for the time specified by the method. Mixing, loading, and settling times are chamber- and specimen-specific.
6. Count the selected squares using one consistent boundary rule. For example, include cells touching the top and left borders and exclude cells touching the bottom and right borders. The opposite convention also works when it is applied consistently.
7. Treat the chamber sides as independent measurements. Apply the laboratory's agreement limit, investigate an unacceptable difference, and repeat the count when required.
8. Calculate and report the concentration with the units and any applicable specimen or method limitation.

An improved Neubauer chamber has a nominal depth of 0.1 mm. A Fuchs-Rosenthal chamber has a nominal depth of 0.2 mm and a larger 16 mm² ruled area, so it holds more fluid over its ruling and suits low-cellularity fluids such as CSF. A low-cellularity fluid may require all available large squares. A denser specimen may use a smaller validated area. Every change in counted area changes the counted volume and must be included in the calculation.^{1,21 Keohane EM, et al. Rodak's Hematology. 2025.2 Alcaide Martín MJ, et al. Automated cell count in body fluids. 2021.}

The general chamber equation is:

Cells/µL = cells counted × dilution factor ÷ (area counted in mm² × chamber depth in mm)

The denominator is the counted volume because 1 cubic millimeter equals 1 microliter. A pooled calculation divides the cells from both chamber sides by their combined counted volume. A method that averages the two side counts divides that average by the volume of one side. Chamber depth, counted squares, and dilution all belong to the specific procedure. The Manual Cell-Counting Calculations lesson explains chamber geometry, dilution factors, duplicate-count examples, and traumatic-tap estimates.

Preparing a stained differential

Direct smears work for cellular fluids. Paucicellular fluids such as normal CSF usually require concentration. In a common cytocentrifuge assembly, a specimen chamber and absorbent card sit against the slide. Centrifugal force deposits cells in a defined area while the card draws away fluid. Cell concentration guides the volume loaded. Add a protein supplement only when the validated method calls for it. Rotor design, funnel, relative centrifugal force, acceleration, spin time, and specimen volume affect cell recovery and appearance. The laboratory validates these settings for its instrument and fluid types.^{1,21 Keohane EM, et al. Rodak's Hematology. 2025.2 Alcaide Martín MJ, et al. Automated cell count in body fluids. 2021.}

After a Wright or Wright-Giemsa stain, scan the entire deposit at low power for cell clumps, organisms, and abnormal cells. A systematic differential follows at higher magnification. Procedures commonly call for 100 cells and may extend the count to 200 or 300 cells when cellularity permits. When the usual target cannot be reached, report the actual number of cells classified, because percentages based on a very small denominator can be misleading.^{11 Keohane EM, et al. Rodak's Hematology. 2025.}

Cytocentrifugation can cause cell loss, uneven recovery, disrupted cytoplasm, nuclear distortion, and artificial cell clustering. These changes can resemble disease. Blasts, lymphoma cells, metastatic cells, or any unexpected atypical population requires review by qualified personnel and, when indicated, flow cytometry or cytopathology. A negative cytocentrifuge preparation from a low-cellularity specimen cannot exclude malignancy.^{1,21 Keohane EM, et al. Rodak's Hematology. 2025.2 Alcaide Martín MJ, et al. Automated cell count in body fluids. 2021.}

CSF formation and laboratory handling

The choroid plexus is traditionally considered a major source of CSF through active secretion. Brain interstitial fluid entering across the ependymal lining also contributes. CSF circulates through the ventricles and subarachnoid spaces, then returns through arachnoid, lymphatic, and other drainage pathways. Tight junctions in choroid-plexus epithelium form the blood-CSF barrier, and tight junctions in central nervous system capillary endothelium help form the blood-brain barrier. These barriers regulate the movement of proteins, cells, antibodies, and drugs. Inflammation, hemorrhage, tumors, impaired flow, and other neurologic disease can change CSF composition.^{55 Xiang J, et al. Mechanisms of cerebrospinal fluid and brain interstitial fluid… 2023.}

Lumbar puncture commonly produces three or four sequentially numbered, sterile, additive-free tubes. Tube allocation varies among laboratories and depends on the requested tests, available volume, and risk of contamination. Route each tube to chemistry, microbiology, cell counts, cytology, or special studies the way the receiving laboratory's collection guide assigns it. Cell counts often use a later tube because blood introduced by the puncture declines across the tube sequence.^{11 Keohane EM, et al. Rodak's Hematology. 2025.} When volume is limited, the laboratory and clinical team set priorities promptly.

The clinician measures opening pressure under defined collection conditions. Position, age, body habitus, sedation, and technique affect interpretation, so a single interval does not apply to every patient. The laboratory records the value and collection conditions when they are provided.

CSF for cell counts and microbiology should reach the laboratory immediately, because cells deteriorate soon after collection. Keep CSF for bacterial culture at room temperature. Never refrigerate it. Selected chemistry, serology, and molecular aliquots may permit refrigeration or freezing under the assay instructions and local procedure. Separate aliquots before a storage condition or processing step can alter another test. For the broader microbiology framework, see Specimen Collection, Transport, and Primary Processing.

CSF and other specified body fluids are treated as other potentially infectious materials under the Occupational Safety and Health Administration bloodborne-pathogens standard. Universal Precautions, suitable personal protective equipment, splash control, and closed containers apply throughout handling.^{66 Occupational Safety and Health… 29 CFR §1910.1030.}

Appearance and blood contamination

Normal CSF is clear and colorless. A clear specimen can still contain an abnormal cell count, infection, hemorrhage, malignant cells, or abnormal chemistry. Appearance is an early observation and does not replace cell counts or other testing.

Xanthochromia is discoloration of the cell-free supernatant. The pigments appear over time, and visual inspection is subjective. The UK National Institute for Health and Care Excellence (NICE) pathway uses spectrophotometric bilirubin measurement when lumbar puncture is performed for suspected subarachnoid hemorrhage. This is a UK pathway. US laboratories have no equivalent universal requirement. The report identifies the method used. Interpretation follows the laboratory's validated procedure and considers the time from symptom onset to lumbar puncture. A very recent hemorrhage may have a clear supernatant, and a traumatic collection can add blood pigments or serum protein.^{77 National Institute for Health and Care… Subarachnoid haemorrhage caused by a ruptured aneurysm. 2022.}

A decline in RBCs across sequential tubes supports a traumatic collection. It cannot rule out intracranial hemorrhage. Traumatic collection and hemorrhage can also occur together. A clot or erythrophagocytosis (macrophage ingestion of red cells) can add supporting evidence. Neither finding determines the source of blood by itself. The measured TNC result remains the primary laboratory result. An estimated correction for peripheral-blood leukocytes may be added according to policy. Never use it to exclude meningitis. The Manual Cell-Counting Calculations lesson shows the paired blood-count equation and its limitations.

CSF cell count and differential

CSF cell concentrations and differential patterns vary with age, collection site, method, and clinical setting. Adult lumbar CSF commonly contains no more than a few nucleated cells per microliter. Newborn and young-infant intervals are higher. Ventricular and shunt specimens require source-specific interpretation. Use the performing laboratory's verified intervals. The ASCP BOC Examination Reference Ranges lesson gives the separate official examination ranges of the American Society for Clinical Pathology (ASCP) Board of Certification (BOC).^{8,98 Tunkel AR, et al. 2017 Infectious Diseases Society of America's clinical practice… 2017.9 World Health Organization. WHO Guidelines on Meningitis Diagnosis, Treatment and Care. 2025.}

Device-associated ventriculitis or shunt infection may produce little inflammation. A normal cell count, glucose, protein, or Gram stain cannot exclude infection. Culture remains the central test. Include the specimen source in the report.^{88 Tunkel AR, et al. 2017 Infectious Diseases Society of America's clinical practice… 2017.}

CSF chemistry and immune studies

CSF chemistry is interpreted with the cell count, specimen appearance, collection site, clinical timing, and paired blood measurements when required. Detailed analytical methods remain with Chemistry and Immunology.^{10,11,910 Higgins V, et al. Best practice recommendations for laboratory analysis and… 2026.11 Mayo Clinic Laboratories. Beta-trace protein, body fluid.9 World Health Organization. WHO Guidelines on Meningitis Diagnosis, Treatment and Care. 2025.}

Immunoglobulin G (IgG) band analysis uses paired serum to distinguish antibodies shared with the circulation from bands restricted to CSF. Matched bands occur at corresponding positions in both samples and can reflect a systemic immune response. When there are no additional CSF-restricted bands, the matched pattern does not itself demonstrate intrathecal IgG synthesis. Additional CSF-restricted bands can support a concurrent intrathecal response even when shared bands are also present. Neither pattern identifies multiple sclerosis by itself.^{1212 Hoshina Y, et al. Matched oligoclonal bands. 2024.}

The IgG index is a separate quantitative calculation. It adjusts the CSF-to-serum IgG ratio for the CSF-to-serum albumin ratio:

IgG index = (CSF IgG ÷ serum IgG) ÷ (CSF albumin ÷ serum albumin)

Concentrations within each ratio must use consistent units. Read the result as increased only against the performing laboratory's interval. The index and oligoclonal bands support a clinical evaluation. Neither result identifies a specific disease. Carbohydrate Metabolism and Glucose Testing covers glucose measurement, and Diseases of the Immune System provides the broader immune-disease context.

Infection testing and pattern correlation

When meningitis is suspected, CSF testing commonly combines Gram stain, culture, TNC count and differential, protein, glucose with a paired blood glucose, and targeted molecular or antigen testing. Blood cultures are collected promptly when bacterial meningitis is suspected and collection is feasible, without delaying urgent antimicrobial treatment. The World Health Organization recommends interpreting these findings together because no single routine CSF result confirms or excludes bacterial meningitis. Culture permits organism recovery and antimicrobial-susceptibility testing. Polymerase chain reaction (PCR) can rapidly detect the organisms included on its panel, including some infections after antimicrobial exposure. Panel limits, low organism burden, and other assay limitations can still produce a negative result in an infected patient.^{9,139 World Health Organization. WHO Guidelines on Meningitis Diagnosis, Treatment and Care. 2025.13 US Food and Drug Administration. QIAstat-Dx Meningitis/Encephalitis Panel. 2024.}